Five-Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study-Reference-Cited by-同舟云学术

Five-Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study

Published:2014-12-17 Issue:1 Volume:15 Page:119-128
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Budde K.¹,Lehner F.²,Sommerer C.³,Reinke P.⁴,Arns W.⁵,Eisenberger U.⁶,Wüthrich R. P.⁷,Mühlfeld A.⁸,Heller K.⁹,Porstner M.¹⁰,Veit J.¹⁰,Paulus E.-M.¹⁰,Witzke O.¹¹

Affiliation:

1. Department of Nephrology; Charité Universitätsmedizin Berlin; Berlin Germany

2. Department of General, Visceral and Transplantation Surgery; Hannover Medical School; Hannover Germany

3. Department of Nephrology; University Hospital Heidelberg; Heidelberg Germany

4. Department of Transplantation; Division of Internal Medicine and Nephrology; Charité Universitätsmedizin Berlin; Berlin Germany

5. Department of Nephrology; Medical Clinic Köln-Merheim; Cologne Germany

6. Department of Nephrology and Hypertension; University of Bern; Inselspital Bern Switzerland

7. Division of Nephrology; University Hospital; Zurich Switzerland

8. Division of Nephrology and Immunology; University Hospital RWTH Aachen; Aachen Germany

9. Department of Medicine; Division of Nephrology; University of Erlangen; Erlangen Germany

10. Novartis Pharma GmbH; Nuremberg Germany

11. Department of Nephrology; University Hospital Essen; University of Duisburg-Essen; Essen Germany

Funder

Novartis GmbH, Nï¿½rnberg, Germany

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference41 articles.

1. Immunosuppressive drugs in kidney transplantation: Impact on patient survival, and incidence of cardiovascular disease, malignancy and infection;Marcén;Drugs,2009

2. Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology;Nankivell;Transplantation,2004

3. Calcineurin inhibitor-sparing regimens in solid organ transplantation: Focus on improving renal function and nephrotoxicity;Flechner;Clin Transplant,2008

4. Calcineurin inhibitors in kidney transplantation: Friend or foe;Casey;Curr Opin Nephrol Hypertens,2011

5. Cyclosporine withdrawal improves long-term graft survival in renal transplantation;Gallagher;Transplantation,2009

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppression in Kidney Transplant Recipients: An Update for the General Nephrologist;Advances in Kidney Disease and Health;2024-09

2. Manejo de masas renales en receptores de trasplante renal. Revisión colaborativa de los grupos de trabajo de trasplante renal y cáncer renal de la sección de jóvenes urológos (YAU) de la Asociación Europea de Urología (EAU);Actas Urológicas Españolas;2023-12

3. How to manage renal masses in kidney transplant recipients? A collaborative review by the EAU-YAU kidney transplantation and renal cancer working groups;Actas Urológicas Españolas (English Edition);2023-12

4. Difficult-to-Treat Rejections in Kidney Transplant Recipients: Our Experience with Everolimus-Based Quadruple Maintenance Therapy;Journal of Clinical Medicine;2023-10-21

5. Systemic inflammation early after kidney transplantation is associated with long-term graft loss: a cohort study;Frontiers in Immunology;2023-10-02